Vitamin D and Sarcopenia: Potential of Vitamin D Supplementation in Sarcopenia Prevention and Treatment

Nutrients. 2020 Oct 19;12(10):3189. doi: 10.3390/nu12103189.

Abstract

Skeletal muscle, the largest organ in the human body, accounting for approximately 40% of body weight, plays important roles in exercise and energy expenditure. In the elderly, there is often a progressive decline in skeletal muscle mass and function, a condition known as sarcopenia, which can lead to bedridden conditions, wheelchair confinement as well as reducing the quality of life (QOL). In developed countries with aging populations, the prevention and management of sarcopenia are important for the improvement of health and life expectancy in these populations. Recently, vitamin D, a fat-soluble vitamin, has been attracting attention due to its importance in sarcopenia. This review will focus on the effects of vitamin D deficiency and supplementation on sarcopenia.

Keywords: atrophy; gene regulation; nuclear receptor; sarcopenia; skeletal muscle; vitamin D.

Publication types

  • Review

MeSH terms

  • Atrophy / genetics
  • Dietary Supplements*
  • Elder Nutritional Physiological Phenomena / physiology*
  • Female
  • Forkhead Box Protein O1 / genetics
  • Forkhead Box Protein O1 / metabolism
  • Gene Expression / drug effects
  • Humans
  • Hypertrophy / genetics
  • Male
  • Muscle Proteins / metabolism
  • Muscle Strength
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Prevalence
  • Quality of Life
  • Recommended Dietary Allowances
  • Sarcopenia / etiology
  • Sarcopenia / metabolism
  • Sarcopenia / prevention & control*
  • Sarcopenia / therapy*
  • TOR Serine-Threonine Kinases / metabolism
  • Vitamin D / administration & dosage*
  • Vitamin D / metabolism
  • Vitamin D / pharmacology
  • Vitamin D / physiology
  • Vitamin D Deficiency

Substances

  • FOXO1 protein, human
  • Forkhead Box Protein O1
  • Muscle Proteins
  • Vitamin D
  • MTOR protein, human
  • TOR Serine-Threonine Kinases